Disclosed are compounds and pharmaceutically acceptable salts, hydrates, solvates, prodrugs, stereoisomers, or tautomers thereof that may cause degradation of various proteins e.g., IKZF2 (Helios). Also disclosed are pharmaceutical compositions containing same, and methods of making and using the compounds to treat diseases and disorders associated with Helios and which may benefit from Helios degradation.
本发明涉及化合物及其制药可接受的盐、
水合物、溶剂合物、前药、立体异构体或互变异构体,其可导致各种蛋白质如IKZF2(Helios)的降解。本发明还涉及含有该化合物的制药组合物,以及使用该化合物治疗与Helios相关的疾病和障碍的方法,这些疾病和障碍可能受益于Helios的降解。